AI-generated summary
The authors studied a redesigned pulsed dye laser with a 15 mm spot in 20 subjects with poikiloderma of Civatte, given four monthly treatments. Seventeen completed the study, and blinded raters scored an average 49% improvement, with side effects limited to mild edema, erythema and purpura. The authors describe the treatment as safe and effective in this small study.
- Participants
- 20
- Who or what was studied
- Adults with poikiloderma of Civatte (20 enrolled, 17 completed)
- Limits stated in the abstract
- The study was small, with 20 enrolled and 17 completing, and the abstract reports no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.